March 3, 2020 / 12:14 PM / a month ago

BRIEF-Can Fite Biopharma Says Filing Drug Safety Update Report Showing Positive Safety Results From Phase II & Phase III Studies Of Namodenoson & Piclidenoson

March 3 (Reuters) - Can Fite Biopharma Ltd:

* CAN FITE BIOPHARMA - FILING DRUG SAFETY UPDATE REPORT SHOWING POSITIVE SAFETY RESULTS FROM PHASE II & PHASE III STUDIES OF NAMODENOSON & PICLIDENOSON Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below